Jane Street
IMVT icon

Jane Street’s Immunovant IMVT Stock Holding History

Jane Street’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09M Buy
+84,312
New +$2.18M ﹤0.01% 4991
2025
Q4 		– Sell
-337,666
Closed -$7.53M – 11728
2025
Q3 		$5.44M Buy
+337,666
New +$5.47M ﹤0.01% 3305
2025
Q2 		– Sell
-52,420
Closed -$793K – 10211
2025
Q1 		$896K Sell
52,420
-453,171
-90% -$9.48M ﹤0.01% 5776
2024
Q4 		$12.5M Buy
505,591
+181,426
+56% +$5.15M ﹤0.01% 1686
2024
Q3 		$9.24M Buy
324,165
+183,848
+131% +$5.42M ﹤0.01% 1987
2024
Q2 		$3.7M Buy
140,317
+72,712
+108% +$2.07M ﹤0.01% 3442
2024
Q1 		$2.18M Sell
67,605
-546,736
-89% -$19.9M ﹤0.01% 3970
2023
Q4 		$25.9M Buy
614,341
+285,829
+87% +$10.5M 0.01% 1067
2023
Q3 		$12.6M Buy
328,512
+167,466
+104% +$3.79M ﹤0.01% 1532
2023
Q2 		$3.06M Buy
161,046
+63,624
+65% +$1.19M ﹤0.01% 3463
2023
Q1 		$1.51M Sell
97,422
-221,649
-69% -$3.85M ﹤0.01% 4293
2022
Q4 		$5.66M Buy
319,071
+302,965
+1,881% +$3.81M ﹤0.01% 2316
2022
Q3 		$90K Buy
+16,106
New +$78.7K ﹤0.01% 8702
2022
Q2 		– Sell
-41,178
Closed -$226K – 10191
2022
Q1 		$226K Buy
41,178
+9,424
+30% +$58.7K ﹤0.01% 8860
2021
Q4 		$270K Sell
31,754
-47,002
-60% -$388K ﹤0.01% 8366
2021
Q3 		$684K Sell
78,756
-38,962
-33% -$351K ﹤0.01% 6693
2021
Q2 		$1.24M Buy
117,718
+104,172
+769% +$1.45M ﹤0.01% 5348
2021
Q1 		$217K Buy
+13,546
New +$357K ﹤0.01% 8152
2020
Q4 		– Sell
-14,713
Closed -$518K – 7769
2020
Q3 		$518K Sell
14,713
-11,608
-44% -$349K ﹤0.01% 5095
2020
Q2 		$640K Buy
26,321
+14,331
+120% +$307K ﹤0.01% 4703
2020
Q1 		$186K Buy
+11,990
New +$180K ﹤0.01% 4684

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Jane Street's IMVT Position: Q1 2026 in Review

Jane Street opened a new position in Immunovant (IMVT) in Q1 2026: 84,312 shares worth $2.09M. The stake represents ﹤0.01% of the portfolio and ranks #4991 among its holdings. This is a return to the name: Jane Street previously reported a position in IMVT as recently as Q3 2025.

Jane Street first reported a position in IMVT in Q1 2020 and has held it in 21 quarters since. The position peaked at $25.9M in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Jane Street held 84,312 shares of Immunovant worth $2.09M as of Q1 2026.
  • Immunovant was a new Jane Street position in Q1 2026.
  • Immunovant made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4991 holding.
  • Jane Street first reported a position in Immunovant in Q1 2020 and has held it in 21 quarters since.
  • Jane Street's Immunovant position peaked at $25.9M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.